Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling
Archives of Biochemistry and Biophysics · 2026-07 · 781 · 110820
DOI: 10.1016/j.abb.2026.110820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2026-07. Verfasst von Min Kyung Pyo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate Scho…. Hauptthemen laut MEDLINE: Reactive Oxygen Species, NADPH Oxidase 1, p38 Mitogen-Activated Protein Kinases, Atherosclerosis. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Seoul National University Bundang Hospital, Chung-Ang University, National Research Foundation of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea.
- Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt; Department of Medical Pharmacology, Medical Faculty, Ataturk University, Erzurum, 25240, Turkey.
- Department of Anatomy, Faculty of Medicine. Ataturk University, Erzurum, 25240, Turkey.
- Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
- Department of Pharmacology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea; Department of Global Innovative Drugs, Graduate School of Chung-Ang University, Seoul, Republic of Korea. Electronic addre…
Förderung
- Seoul National University Bundang Hospital
- Chung-Ang University
- National Research Foundation of Korea
Zitieren
APA
Pyo, M. K., Park, H. S., Ko, J. H., Lim, D. S., Gwon, H. J., Abd El-Aty, A. M., Yağan, R., Song, J. H., Shin, Y. K., Jeong, J. H., & Jung, T. W. (2026). Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling. Archives of Biochemistry and Biophysics, 781, 110820. https://doi.org/10.1016/j.abb.2026.110820
Vancouver
Pyo MK, Park HS, Ko JH, Lim DS, Gwon HJ, Abd El-Aty AM, et al. Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling. Archives of Biochemistry and Biophysics. 2026;781:110820. doi:10.1016/j.abb.2026.110820
BibTeX
@article{Pyo2026,
author = {Pyo, Min Kyung and Park, Hyung Sub and Ko, Jun Hwi and Lim, Do Su and Gwon, Hyeon Ji and Abd El-Aty, A M and Yağan, Ridvan and Song, Jin-Ho and Shin, Yong Kyoo and Jeong, Ji Hoon and Jung, Tae Woo},
title = {Hepassocin drives EGFR-dependent endothelial atherogenic activation via NOX1/ROS amplification and p38 signaling},
journal = {Archives of Biochemistry and Biophysics},
year = {2026},
volume = {781},
pages = {110820},
doi = {10.1016/j.abb.2026.110820}
}
EUVIMED